Quantitation of T cell depletion by limiting dilution analysis

Related Experiment Videos

L Moretti1, S Corpuz, L Giuliodori

  • 1Divisione di Ematologia, USL n. 3, Pesaro, Italy.

Haematologica
|May 1, 1991
PubMed
Abstract

Insights

A new culture method accurately counts residual T cells in marrow after antibody or immunotoxin treatment. This technique helps understand T cell depletion and its impact on graft failure rates in clinical trials.

Area of Science:

  • Immunology
  • Hematology
  • Cell Biology

Background:

  • Evaluating methods for enumerating residual T cells in marrow post-treatment.
  • Assessing T cell depletion after antibody/complement or immunotoxin therapy.

Purpose of the Study:

  • To evaluate a novel culture method for quantifying residual T cells in bone marrow.
  • To assess the efficacy of T cell depletion strategies in marrow transplantation.

Main Methods:

  • Culturing marrow cells at limiting dilutions with phytohemagglutinin and Epstein Barr virus transformed lymphoblastoid cells.
  • Measuring interleukin-2 (IL-2) in supernates via a cell proliferation assay to enumerate T cells.
  • Utilizing a simple, reliable, objective, and rapid enumeration technique.

Main Results:

  • Approximately 6% of untreated marrow mononuclear cells produced IL-2 in clonal cultures.
  • Antibody and complement treatment achieved a 3.7 log depletion of IL-2 precursors.
  • Ricin A chain anti-CD3 immunotoxin treatment resulted in a 3.0 log depletion of IL-2 precursors.

Conclusions:

  • The developed method offers a reliable way to assess T cell depletion in marrow.
  • Extreme T cell depletion may contribute to graft failure observed in clinical trials.
  • Clinical correlations are ongoing to validate the method against previous techniques.

Related Concept Videos